NCT01863173View on ClinicalTrials.gov

Effect of Metoprolol on Thalassemia Cardiomyopathy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

December 31, 2012

Conditions
B Thalassemia
Interventions
DRUG

metoprolol

using B blocker in patient group

DRUG

placebo

placebo to control group

Trial Locations (1)

Unknown

Shiraz University of Medical Sciences, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT01863173 - Effect of Metoprolol on Thalassemia Cardiomyopathy | Biotech Hunter | Biotech Hunter